DE NICOLA, Luca
 Distribuzione geografica
Continente #
EU - Europa 20.573
NA - Nord America 13.411
AS - Asia 9.679
SA - Sud America 1.481
Continente sconosciuto - Info sul continente non disponibili 464
AF - Africa 128
OC - Oceania 8
Totale 45.744
Nazione #
RU - Federazione Russa 13.410
US - Stati Uniti d'America 13.189
SG - Singapore 3.418
IE - Irlanda 2.179
CN - Cina 2.115
HK - Hong Kong 1.553
BR - Brasile 1.237
UA - Ucraina 1.171
IT - Italia 956
GB - Regno Unito 953
VN - Vietnam 899
DE - Germania 680
IN - India 522
TR - Turchia 333
FI - Finlandia 321
KR - Corea 319
SE - Svezia 299
GR - Grecia 188
JP - Giappone 126
BD - Bangladesh 120
FR - Francia 112
AR - Argentina 96
CA - Canada 93
MX - Messico 63
AT - Austria 58
NL - Olanda 51
BE - Belgio 43
EC - Ecuador 42
IQ - Iraq 36
ES - Italia 34
PK - Pakistan 33
ZA - Sudafrica 33
CZ - Repubblica Ceca 30
CO - Colombia 29
ID - Indonesia 29
MA - Marocco 21
TN - Tunisia 21
MY - Malesia 20
VE - Venezuela 20
PH - Filippine 19
CL - Cile 18
JM - Giamaica 18
IR - Iran 17
PL - Polonia 16
PY - Paraguay 16
UZ - Uzbekistan 16
SA - Arabia Saudita 15
KZ - Kazakistan 12
CR - Costa Rica 11
IL - Israele 11
KE - Kenya 11
LT - Lituania 10
AE - Emirati Arabi Uniti 9
CH - Svizzera 9
UY - Uruguay 9
EG - Egitto 8
EU - Europa 8
NI - Nicaragua 8
PE - Perù 8
PT - Portogallo 8
TH - Thailandia 8
HU - Ungheria 7
SC - Seychelles 7
TW - Taiwan 6
AL - Albania 5
AU - Australia 5
BO - Bolivia 5
NP - Nepal 5
OM - Oman 5
RS - Serbia 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GE - Georgia 4
KG - Kirghizistan 4
LB - Libano 4
DK - Danimarca 3
EE - Estonia 3
JO - Giordania 3
LV - Lettonia 3
MK - Macedonia 3
RO - Romania 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BZ - Belize 2
DZ - Algeria 2
GA - Gabon 2
GT - Guatemala 2
HN - Honduras 2
KH - Cambogia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
Totale 45.252
Città #
Moscow 4.773
Dublin 2.177
Jacksonville 1.753
Santa Clara 1.631
Hong Kong 1.537
San Jose 1.391
Singapore 1.315
Chandler 1.119
Ashburn 701
Council Bluffs 586
Chicago 496
Bengaluru 441
Princeton 344
Hefei 316
Ho Chi Minh City 309
Seoul 305
Medford 279
Wilmington 270
Beijing 262
Dallas 227
Hanoi 213
Roxbury 210
Boardman 209
Ann Arbor 168
New York 158
San Mateo 157
Falls Church 133
The Dalles 126
Woodbridge 119
São Paulo 114
Naples 113
Los Angeles 110
Istanbul 96
Munich 96
Cambridge 86
Des Moines 80
Bremen 75
Nanjing 69
Jinan 62
Milan 59
Caserta 56
Da Nang 54
Rome 51
Houston 47
Rio de Janeiro 46
Brussels 42
Nuremberg 42
Norwalk 41
Haiphong 38
Frankfurt am Main 36
Mountain View 35
Shenyang 35
Tokyo 35
Belo Horizonte 34
Napoli 33
Zhengzhou 33
Saint Petersburg 32
Guangzhou 30
Orem 30
Atlanta 29
Brooklyn 28
Shanghai 28
Vienna 28
Brno 27
Tianjin 24
Helsinki 23
Curitiba 22
Changsha 21
Biên Hòa 20
Phoenix 20
Düsseldorf 19
Ercolano 19
Hangzhou 19
Hải Dương 19
Ningbo 19
San Francisco 19
Chennai 18
Nanchang 18
Taizhou 18
Bologna 17
Campinas 17
London 17
Mexico City 17
Quito 17
Turku 17
Johannesburg 16
Brasília 15
Montreal 15
Philadelphia 15
Seattle 15
Sorocaba 15
Taiyuan 15
Toronto 15
Amsterdam 14
Boston 14
Buenos Aires 14
Dhaka 14
Falkenstein 14
Lanzhou 14
Kingston 13
Totale 24.193
Nome #
Ethanol and in-vitro Vascular Reactivity of Rats Mesenteric-Artery 839
Sustained Recovery of Kidney Function in Patients with ESKD under Chronic Dialysis Treatment: Systematic Review and Meta-Analysis 470
Empagliflozin in Patients with Chronic Kidney Disease 243
A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population 238
Ruolo del refilling plasmatico dopo dialisi alternativa: valutazione dei dati bioimpedenzometrici 207
Reassessment of Ambulatory Blood Pressure Improves Renal Risk Stratification in Nondialysis Chronic Kidney Disease: Long-Term Cohort Study 198
L'impiego dell’ Emodiafiltrazione con reinfusione endogena (HFR) nell'infiammazione cronica idiopatica: una possibile alternativa terapeutica? 183
Amino acid loss during dialysis treatment 183
Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels 182
Absence of acute nephrotoxicity with low doses of cyclosporin: experimental study in the rat 178
Alterazioni del bilancio idro-elettrolitico nell’insufficienza renale acuta: implicazioni cliniche 178
Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology 177
Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects 176
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter Prospective Cohort Study 174
[Anti-diabetics and chronic kidney disease] 172
[Iron deficiency in ND-CKD: from diagnosis to treatment] 171
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 170
[Hyperuricaemia and Chronic Kidney Disease] 170
Antiproteinuric Response to Dual Blockade of RAS in Primary Glomerulonephritis: Meta-Analysis and Meta-Regression 169
Conversion of darbepoetin to low doses of CERA maintains hemoglobin levels in non-dialysis chronic kidney disease patients 168
Assessment of achieved clinic and ambulatory BP recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. 168
Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care 165
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 165
CHRONIC CYCLOSPORINE A NEPHROTOXICITY - A MORPHOLOGICAL AND FUNCTIONAL-STUDY IN RATS 163
Daily nutrient intake in hemodialysis. 163
Assesement of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients wih CKD: a multicenter prospective cohort study 163
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy 162
[Clinical experience with ferric carboxymaltose in non-dialysis chronic kidney disease] 162
Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure 161
Antiproteinuric response to add-on aliskiren in proteinuric patients treated with dual blockade of the renin-angiotensin system: a 12-month prospective uncontrolled study 160
Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis 160
[Peritoneal dialysis catheter infection with abscess of the abdominal wall in a ADPKD patient] 160
Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease 157
Achievement of target blood pressure levels in chronic kidney disease: a salty question ? 157
Area Deprivation and Risk of Death and CKD Progression: Long-Term Cohort Study in Patients under Unrestricted Nephrology Care 157
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 156
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 155
15-year-change of phenotype and prognosis in non-dialysis CKD patients referred to a nephrology clinic 154
Alterations of hydro-electrolyte balance in acute renal failure: clinical implications 154
Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease 153
Blood pressure variability, mortality, and cardiovascular outcomes in CKD patients 153
[Epidemiology and prognosis of chronic kidney disease in Italy] 153
Clinical management of the patient affected with acute renal failure (ARF) secondary to volume depletion 152
Abnormalities of bioimpedance measures in overweight and obese hemodialyzed patients 151
[Hyperkalemia treatment in chronic kidney disease patients: overview on new cation exchange resins and possible therapeutic approaches] 150
Prevalence and Prognostic Role of Resistant Hypertension in Chronic Kidney Disease Patients 149
[Census of the renal and dialysis units by Italian Society of Nephrology: structure and organization for renal patient assistance in Italy (2014-2015)] 149
Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers 148
Renal Functional Reserve (RFR) And Antihypertensive Treatments (RXP) in Rats with Goldblatt Hypertension (2K1C) 147
Acute cyclosporine A nephrotoxicity 147
A new diuretic: the Atrial Natriuretic Peptide 147
Acute renal and immunological effects of low-dose cyclosporin in humans 146
Management of hypertension in patients with CKD: differences between primary and tertiary care settings 146
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 146
Disfunzione renale nell’anziano: processo fisiologico o malattia? 145
Ruolo dell’ossido nitrico nella regolazione dell’emodinamica glomerulare 144
Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey 142
Management of hypertension in chronic kidney disease: the Italian multicenter study. 141
Epidemiology of chronic kidney disease in Italy: the CARHES study 141
Anemia: A Connection Between Heart Failure and Kidney Failure 141
Effect of hemodiafiltration with endogenous reinfusion on overt idiopathic chronic inflammation in maintenance hemodialysis patients: A multicenter longitudinal study. 140
Epidemiology of CKD Regression in Patients under Nephrology Care 140
Antiproteinuric effect of paricalcitol in kidney transplant recipients with severe proteinuria: a prospective cohort study 139
Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease 139
Renal Disease 139
Sodium removal by peritoneal dialysis: a systematic review and meta-analysis 139
Ferric carboxymatose in non-hemodialysis ckd patients: A longitudinal cohort study 139
Role of paracalcitol in the management of non-dialysis CKD: state of art and unmeet needs. 138
Prevalence and Prognosis of Mild Anemia in Non-Dialysis CKD: A Prospective Cohort Study in Outpatient Renal Clinics 138
Comprehensive audit of antihypertensive treatment in patients with chronic renal insufficiency (CRI): The Italian Multicentre survey 138
Acute effects of low-dose cyclosporine on renal function in normal subjects 137
Acute effects of cyclosporine on glomerular dynamics--micropuncture study in the rat 137
Sodium intake and chronic kidney disease 137
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 136
AMBULATORY BLOOD PRESSURE (ABP) AND RESISTANT HYPERTENSION (RH): TWO INCREMENTAL PREDICTORS OF LONG TERM COMPLICATIONS IN NON-DIALYSIS CKD 136
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 136
Epidemiology of chronic kidney disease in Italy: current state and contribution of the CARHES study. 136
Sex difference in cardiovascular risk in patients with chronic kidney disease: pooled analysis of four cohort studies 135
Role of inhibition of atrial natriuretic factor release in the down-regulation of salt excretion 135
Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis 135
Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. 134
Management of hypertension in chronic kidney disease 133
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy 133
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 133
Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound 132
Volume-Independent Sodium Toxicity in Peritoneal Dialysis: New Insights from Bench to Bed 131
Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study 131
Epidemiologia e Prognosi della Malattia Renale Cronica in Italia 131
Epidemiology of chronic kidney disease in Italy 131
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. 131
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics 131
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy 131
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease 131
Are all erythropoiesis-stimulating agents created equal? 131
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 130
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 130
Very low-protein diet plus ketoacids in chronic kidney disease and risk of death during end-stage renal disease: an historical, cohort, controlled study. 130
Prevalence and clinical correlates of white coat hypertension in chronic kidney disease 130
Heart Failure in chronic kidney disease: from epidemiology to therapy. 130
Rebound post-dialitico della fosforemia: implicazioni patogenetiche e cliniche 130
Totale 16.152
Categoria #
all - tutte 160.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.316


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.061 0 0 43 82 726 19 44 56 83 145 213 650
2022/20234.441 422 137 318 363 398 342 10 253 1.992 37 75 94
2023/20241.699 150 49 74 172 613 96 38 30 34 32 125 286
2024/20255.897 16 84 81 184 940 893 821 499 637 998 410 334
2025/202622.817 887 1.204 1.168 1.078 1.769 12.565 1.170 983 881 563 326 223
2026/20272.417 451 712 1.254 0 0 0 0 0 0 0 0 0
Totale 45.744